New Demand in an Old Market – IQVIA 09/05/2023 majac Diabetes Mounjaro launched as a diabetes drug when only two out of the then nine GLP-1 therapies were indicated for obesity. However, an unprecedented mix of … Share on FacebookTweetFollow usSave